Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

Cited by (1,001)

Items 101–200 of 1,001

  1. The interaction of HIV with dendritic cells: outcomes and pathways
    Vincent Piguet, Ralph M. Steinman · 2007 · Trends in Immunology
  2. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis
    Simone Visosky Ward, Cyril X. George, Megan J. Welch, Li‐Ying Liou, Bumsuk Hahm, Hanna A. Lewicki, Juan Carlos de la Torre, Charles E. Samuel, Michael B. A. Oldstone · 2010 · Proceedings of the National Academy of Sciences
  3. Identification of Two Distinct Human Immunodeficiency Virus Type 1 Vif Determinants Critical for Interactions with Human APOBEC3G and APOBEC3F
    Rebecca A Russell, Vinay K. Pathak · 2007 · Journal of Virology
  4. Human Immunodeficiency Virus Type 1 Vpr Induces the Degradation of the UNG and SMUG Uracil-DNA Glycosylases
    Bärbel Schröfelbauer, Qin Yu, Samantha G. Zeitlin, Nathaniel Roy Landau · 2005 · Journal of Virology
  5. Retrovirus Restriction Factors
    Stephen P. Goff · 2004 · Molecular Cell
  6. The APOBEC3 Family of Retroelement Restriction Factors
    Eric W. Refsland, Reuben S. Harris · 2013 · Current topics in microbiology and immunology
  7. Infection Barriers to Successful Xenotransplantation Focusing on Porcine Endogenous Retroviruses
    Denner, Joachim, Tönjes, Ralf R. · 2012 · Clinical Microbiology Reviews
  8. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition
    M. Kinomoto, Takayuki Kanno, Mari Shimura, Yukihito Ishizaka, Asato Kojima, T. Kurata, Tetsutaro Sata, Kenzo Tokunaga · 2007 · Nucleic Acids Research
  9. APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells
    Grégory Berger, Stéphanie Durand, Guillaume Fargier, Xuan-Nhi Nguyen, Stéphanie Cordeil, Serge Bouaziz, Delphine M. Muriaux, Jean‐Luc Darlix, Andrea Cimarelli · 2011 · PLoS Pathogens
  10. Functions and regulation of the APOBEC family of proteins
    Harold C. Smith, Ryan P. Bennett, Ayşe Kizilyer, William M. McDougall, Kimberly M. Prohaska · 2011 · Seminars in Cell and Developmental Biology
  11. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif
    Guo, Yingying, Dong, Liyong, Qiu, Xiaolin, Wang, Yishu, Zhang, Bailing, Liu, Hongnan, Yu, You, Zang, Yi, Yang, Maojun, Huang, Zhiwei · 2014 · Nature
  12. Early steps of retrovirus replicative cycle
    Sébastien Nisole, Ali Saı̈b · 2004 · Retrovirology
  13. Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All
    Belete Ayele Desimmie, Krista A. Delviks‐Frankenberry, Ryan C. Burdick, Dongfei Qi, Taisuke Izumi, Vinay K. Pathak · 2013 · Journal of Molecular Biology
  14. Biochemical Activities of Highly Purified, Catalytically Active Human APOBEC3G: Correlation with Antiviral Effect
    Yasumasa Iwatani, Hiroaki Takeuchi, Klaus Strebel, Judith G. Levin · 2006 · Journal of Virology
  15. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase
    Rodolphe Suspène · 2004 · Nucleic Acids Research
  16. Human Retroviral Host Restriction Factors APOBEC3G and APOBEC3F Localize to mRNA Processing Bodies
    Michael J. Wichroski, G. Brett Robb, Tariq M. Rana · 2006 · PLoS Pathogens
  17. Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging
    Kun Luo, Bindong Liu, Zuoxiang Xiao, Yunkai Yu, Xianghui Yu, Robert J. Gorelick, Xiao-Fang Yu · 2004 · Journal of Virology
  18. Inhibition of \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{tRNA}_{3}^{\mathrm{Lys}}\) \end{document}-Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 Replication
    Fei Guo, Shan Cen, Meijuan Niu, Jenan Saadatmand, Lawrence Kleiman · 2006 · Journal of Virology
  19. Methylation of Tat by PRMT6 Regulates Human Immunodeficiency Virus Type 1 Gene Expression
    Marie‐Chloé Boulanger, Chen Liang, Rodney S. Russell, Rongtuan Lin, Mark T. Bedford, Mark A. Wainberg, Stéphane Richard · 2004 · Journal of Virology
  20. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein
    Martin Löchelt, Fabian Romen, Patrizia Bastone, Heide Muckenfuß, Nadine Kirchner, Yong-Boum Kim, Uwe Truyen, Uwe Rösler, Battenberg Marion, Ali Saı̈b et al. · 2005 · Proceedings of the National Academy of Sciences
  21. APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS
    Ping An, Gabriela Bleiber, Priya Duggal, George W. Nelson, Margaret May, Bastien Mangeat, Irene Alobwede, Didier Trono, David Vlahov, Sharyne M Donfield et al. · 2004 · Journal of Virology
  22. The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain
    Guylaine Haché, Mark T. Liddament, Reuben S. Harris · 2005 · Journal of Biological Chemistry
  23. Evolution of the deaminase fold and multiple origins of eukaryotic editing and mutagenic nucleic acid deaminases from bacterial toxin systems
    Lakshminarayan M. Iyer, Dapeng Zhang, Igor B. Rogozin, L. Aravind · 2011 · Nucleic Acids Research
  24. The role of endogenous and exogenous DNA damage and mutagenesis
    Errol C. Friedberg, Lisa D. McDaniel, Roger Alan Schultz · 2003 · Current Opinion in Genetics & Development
  25. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals
    Rebecca S. LaRue, S. Jönsson, Kevin A.T. Silverstein, Mathieu Lajoie, Denis Bertrand, Nadia El-Mabrouk, Isidro Hötzel, Valgerður Andrésdóttir, Timothy P. L. Smith, Reuben S. Harris · 2008 · BMC Molecular Biology
  26. Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation
    Hendrik Huthoff, Michael H. Malim · 2007 · Journal of Virology
  27. The Vpr protein from HIV-1: distinct roles along the viral life cycle
    Erwann Le Rouzic, Serge Bénichou · 2005 · Retrovirology
  28. APOBEC3 inhibits mouse mammary tumour virus replication in vivo
    Chioma M. Okeoma, Nika Lovšin, Boris Matija Peterlin, Susan R. Ross · 2007 · Nature
  29. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
    John S. Albin, Reuben S. Harris · 2010 · Expert Reviews in Molecular Medicine
  30. The Enzymatic Activity of CEM15/Apobec-3G Is Essential for the Regulation of the Infectivity of HIV-1 Virion but Not a Sole Determinant of Its Antiviral Activity
    Keisuke Shindo, Akifumi Takaori‐Kondo, Masayuki Kobayashi, Aierken Abudu, Keiko Fukunaga, Takashi Uchiyama · 2003 · Journal of Biological Chemistry
  31. The Anti-HIV-1 Editing Enzyme APOBEC3G Binds HIV-1 RNA and Messenger RNAs That Shuttle between Polysomes and Stress Granules
    Susan L. Kozak, Mariana Marin, Kristine M. Rose, Cory E. Bystrom, David Kabat · 2006 · Journal of Biological Chemistry
  32. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities
    Marc‐André Langlois · 2005 · Nucleic Acids Research
  33. Adaptive Evolution and Antiviral Activity of the Conserved Mammalian Cytidine Deaminase APOBEC3H
    Molly OhAinle, Julie A. Kerns, Harmit Singh Malik, Michael Emerman · 2006 · Journal of Virology
  34. Host Restriction Factors Blocking Retroviral Replication
    Daniel Wolf, Stephen P. Goff · 2008 · Annual Review of Genetics
  35. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5–E3 ligase through a HCCH motif to suppress APOBEC3G
    Kun Luo, Zuoxiang Xiao, Elana S. Ehrlich, Yunkai Yu, Bindong Liu, Shu Sen Zheng, Xiao-Fang Yu · 2005 · Proceedings of the National Academy of Sciences
  36. Foamy Virus Bet Proteins Function as Novel Inhibitors of the APOBEC3 Family of Innate Antiretroviral Defense Factors
    Rebecca A Russell, Heather L. Wiegand, Michael D. Moore, Alexandra Schäfer, Myra O. McClure, Bryan R. Cullen · 2005 · Journal of Virology
  37. Viral RNA Is Required for the Association of APOBEC3G with Human Immunodeficiency Virus Type 1 Nucleoprotein Complexes
    Mohammad A. Khan, Sandra Kao, Eri Miyagi, Hiroaki Takeuchi, Ritu Goila-Gaur, Sandrine Opi, Clay L. Gipson, Tristram G. Parslow, Hinh Ly, Klaus Strebel · 2005 · Journal of Virology
  38. Use of Endogenous Retroviral Sequences (ERVs) and structural markers for retroviral phylogenetic inference and taxonomy
    Patric Jern, Göran Sperber, Jonas Blomberg · 2005 · Retrovirology
  39. Rapid evolution of primate antiviral enzyme APOBEC3G
    Jianzhi Zhang · 2004 · Human Molecular Genetics
  40. Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses
    Réjean Cantin, Sylvie Méthot, Michel J. Tremblay · 2005 · Journal of Virology
  41. A Zinc-binding Region in Vif Binds Cul5 and Determines Cullin Selection
    Andrew Mehle, Elaine R. Thomas, Kottampatty S. Rajendran, Dana H. Gabuzda · 2006 · Journal of Biological Chemistry
  42. The ubiquitin system, disease, and drug discovery
    Matthew D. Petroski · 2008 · BMC Biochemistry
  43. APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis
    Holly A. Sadler, Mark D. Stenglein, Reuben S. Harris, Louis M. Mansky · 2010 · Journal of Virology
  44. RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1
    Hendrik Huthoff, Flavia Autore, Sarah Gallois‐Montbrun, Franca Fraternali, Michael H. Malim · 2009 · PLoS Pathogens
  45. G→A Hypermutation in Protease and Reverse Transcriptase Regions of Human Immunodeficiency Virus Type 1 Residing in Resting CD4 + T Cells In Vivo
    Tara L. Kieffer, Patty Kwon, Richard E. Nettles, Yefei Han, Stuart C. Ray, Robert F. Siliciano · 2005 · Journal of Virology
  46. Lambda Interferon Inhibits Human Immunodeficiency Virus Type 1 Infection of Macrophages
    Wei Hou, Xu Wang, Li Ye, Lin Zhou, Zhanqiu Yang, Eric Riedel, Wen‐Zhe Ho · 2009 · Journal of Virology
  47. Deamination-Independent Inhibition of Hepatitis B Virus Reverse Transcription by APOBEC3G
    David H. A. Nguyen, Suryaram Gummuluru, Jianming Hu · 2007 · Journal of Virology
  48. HIV-1 dynamics in vivo: implications for therapy
    Viviana R. Simon, David D. Ho · 2003 · Nature Reviews Microbiology
  49. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism
    Rodolphe Suspène, Marie-Ming Aynaud, Denise Guétard, Michel Henry, Grace Eckhoff, Agnès Marchio, Pascal Pineau, Anne Dejean, Jean‐Pierre Vartanian, Simon Wain–Hobson · 2011 · Proceedings of the National Academy of Sciences
  50. Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1
    Marta Colomer-Lluch, Alba Ruiz, Arnaud Moris, Júlia G. Prado · 2018 · Frontiers in Immunology
  51. Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
    Jean‐Pierre Vartanian, Michel Henry, Agnès Marchio, Rodolphe Suspène, Marie-Ming Aynaud, Denise Guétard, Minerva Cervantes-Gonzalez, Carlo Battiston, Vincenzo Mazzaferro, Pascal Pineau et al. · 2010 · PLoS Pathogens
  52. 7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G
    Tao Wang, Chunjuan Tian, Wenyan Zhang, Kun Luo, Phuong Thi Nguyen Sarkis, Lillian Yu, Bindong Liu, Yunkai Yu, Xiao‐Fang Yu · 2007 · Journal of Virology
  53. Current Perspectives on HIV-1 Antiretroviral Drug Resistance
    Pinar Iyidogan, Karen S. Anderson · 2014 · Viruses
  54. APOBEC Enzymes as Targets for Virus and Cancer Therapy
    Olson, Margaret E., Harris, Reuben S., Harki, Daniel A. · 2018 · Cell Chemical Biology
  55. Bile acids are essential for porcine enteric calicivirus replication in association with down-regulation of signal transducer and activator of transcription 1
    Kyeong‐Ok Chang, Stanislav V. Sosnovtsev, Gaël Belliot, Yunjeong Kim, Linda J. Saif, Kim Y. Green · 2004 · Proceedings of the National Academy of Sciences
  56. DNA Deamination in Immunity: AID in the Context of Its APOBEC Relatives
    Silvestro Giovanni Conticello, Marc‐André Langlois, Zizhen Yang, Michael S. Neuberger · 2007 · Advances in immunology
  57. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev
    Jianhua Fang, Satoshi Kubota, Bin Yang, Naiming Zhou, Hui Zhang, Roseline Godbout, Roger J. Pomerantz · 2004 · Virology
  58. A macaque model of HIV-1 infection
    Théodora Hatziioannou, Zandrea Ambrose, Nancy P. Y. Chung, Michael Piatak, Fang Yuan, Charles M. Trubey, Vicky J. Coalter, Rebecca F. Kiser, Doug Schneider, Jeremy V Smedley et al. · 2009 · Proceedings of the National Academy of Sciences
  59. Selective inhibition of Alu retrotransposition by APOBEC3G
    Amy E. Hulme, Hal P. Bogerd, Bryan R. Cullen, John V. Moran · 2006 · Gene
  60. The origin of genetic diversity in HIV-1
    Redmond P. Smyth, Miles P. Davenport, Johnson Mak · 2012 · Virus Research
  61. Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination
    Lela Lackey, Emily K. Law, William L. Brown, Reuben S. Harris · 2013 · Cell Cycle
  62. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C Complex Is Essential for Vif Function
    Masayuki Kobayashi, Akifumi Takaori‐Kondo, Yasuhiro Miyauchi, Kazuhiro Iwaï, Takashi Uchiyama · 2005 · Journal of Biological Chemistry
  63. APOBEC3G Inhibits DNA Strand Transfer during HIV-1 Reverse Transcription
    Xiaoyu Li, Fei Guo, Li Zhang, Lawrence Kleiman, Shan Cen · 2007 · Journal of Biological Chemistry
  64. Regulation of Apobec3F and Human Immunodeficiency Virus Type 1 Vif by Vif-Cul5-ElonB/C E3 Ubiquitin Ligase
    Bindong Liu, Phuong Thi Nguyen Sarkis, Kun Luo, Yunkai Yu, Xiao-Fang Yu · 2005 · Journal of Virology
  65. Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1
    Eri Miyagi, Sandrine Opi, Hiroaki Takeuchi, Mohammad Hassaan Khan, Ritu Goila-Gaur, Sandra Kao, Klaus Strebel · 2007 · Journal of Virology
  66. Distinct Patterns of Cytokine Regulation of APOBEC3G Expression and Activity in Primary Lymphocytes, Macrophages, and Dendritic Cells
    Kim Stopak, Ya‐Lin Chiu, Jerry Kropp, Robert M. Grant, Warner C. Greene · 2006 · Journal of Biological Chemistry
  67. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy
    Mary F. Kearney, Ann P. Wiegand, Wei Shao, John M. Coffin, John W. Mellors, Michael M. Lederman, Rajesh Tim Gandhi, Brandon F. Keele, Jonathan Z. Li · 2015 · Journal of Virology
  68. Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
    Subramanian Venkatesan, Rachel Rosenthal, Nnennaya Kanu, Nicholas McGranahan, Jiří Bártek, Sergio A. Quezada, Jonathan Hare, Reuben S. Harris, Charles Swanton · 2018 · Annals of Oncology
  69. Global virus outbreaks: Interferons as 1st responders
    Ben X. Wang, Eleanor N. Fish · 2019 · Seminars in Immunology
  70. Differential Restriction of Human Immunodeficiency Virus Type 2 and Simian Immunodeficiency Virus SIVmac by TRIM5α Alleles
    Laura M. J. Ylinen, Zuzana Keckesova, Sam J. Wilson, Srin Ranasinghe, Greg J. Towers · 2005 · Journal of Virology
  71. The DNA Deaminase Activity of Human APOBEC3G Is Required for Ty1, MusD, and Human Immunodeficiency Virus Type 1 Restriction
    April J. Schumacher, Guylaine Haché, Donna A. MacDuff, William L. Brown, Reuben S. Harris · 2008 · Journal of Virology
  72. Host factors influencing susceptibility to HIV infection and AIDS progression
    Juan Lama, Vicente Planelles · 2007 · Retrovirology
  73. Restriction of Foamy Viruses by APOBEC Cytidine Deaminases
    Frédéric Delebecque, Rodolphe Suspène, Sara Calattini, Nicoletta Casartelli, Ali Saı̈b, Alain Froment, Simon Wain–Hobson, Antoine Gessain, Jean‐Pierre Vartanian, Olivier Schwartz · 2005 · Journal of Virology
  74. FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells
    Demet Nalbant, Hyewon Youn, S Isil Nalbant, Savitha S. Sharma, Everardo Cobos, ELMUS G. BEALE, Yang Du, Simon C. Williams · 2005 · BMC Genomics
  75. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast
    April J. Schumacher, Dwight V. Nissley, Reuben S. Harris · 2005 · Proceedings of the National Academy of Sciences
  76. Alpha Interferon Potently Enhances the Anti-Human Immunodeficiency Virus Type 1 Activity of APOBEC3G in Resting Primary CD4 T Cells
    Keyang Chen, Jialing Huang, Chune Zhang, Sophia Huang, Giuseppe Nunnari, Fengxiang Wang, Xiangrong Tong, Ling Gao, Kristi Nikisher, Hui Zhang · 2006 · Journal of Virology
  77. Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H
    Vanessa B. Soros, Wes M. Yonemoto, Warner C. Greene · 2007 · PLoS Pathogens
  78. Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo
    Rodolphe Suspène, Marie-Ming Aynaud, Stefanie Koch, David Pasdeloup, Marc Labétoulle, B Gaertner, Jean‐Pierre Vartanian, Andreas Meyerhans, Simon Wain–Hobson · 2011 · Journal of Virology
  79. Uracil DNA Glycosylase Is Dispensable for Human Immunodeficiency Virus Type 1 Replication and Does Not Contribute to the Antiviral Effects of the Cytidine Deaminase Apobec3G
    Shari M. Kaiser, Michael Emerman · 2005 · Journal of Virology
  80. APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response
    Alexander P. Glaser, Damiano Fantini, Yiduo Wang, Yanni Yu, Kalen J. Rimar, Joseph R. Podojil, Stephen D. Miller, Joshua J. Meeks · 2017 · Oncotarget
  81. G to A hypermutation of hepatitis B virus†
    Chiemi Noguchi, Hiromi Ishino, Masataka Tsuge, Yoshifumi Fujimoto, Michio Imamura, Shoichi Takahashi, Kazuaki Chayama · 2005 · Hepatology
  82. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection
    Marjorie Pion, Angela Granelli‐Piperno, Bastien Mangeat, Romaine Stalder, Rafael Correa‐Rocha, Ralph M. Steinman, Vincent Piguet · 2006 · The Journal of Experimental Medicine
  83. HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation
    Lulu Yu, Vladimır Majerčiak, Zhi‐Ming Zheng · 2022 · International Journal of Molecular Sciences
  84. Endogenous retroviruses: acquisition, amplification and taming of genome invaders
    Marie Dewannieux, Thiérry Heidmann · 2013 · Current Opinion in Virology
  85. Human Immunodeficiency Virus, Restriction Factors, and Interferon
    Stuart J. D. Neil, Paul D. Bieniasz · 2009 · Journal of Interferon & Cytokine Research
  86. Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases
    Sachini U. Siriwardena, Kang Chen, Ashok S. Bhagwat · 2016 · Chemical Reviews
  87. Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes
    Yuichi Tanaka, Hiroyuki Marusawa, Hiroshi Seno, Yuko Mizuno Matsumoto, Yoshihide Ueda, Yuzo Kodama, Yoko Endo, Junichi Yamauchi, Tomonori Matsumoto, Akifumi Takaori‐Kondo et al. · 2006 · Biochemical and Biophysical Research Communications
  88. APOBEC3G targets human T-cell leukemia virus type 1
    Amane Sasada, Akifumi Takaori‐Kondo, Kotaro Shirakawa, Masayuki Kobayashi, Abudu Aierkin, Masakatsu Hishizawa, Kazunori Imada, Yuetsu Tanaka, Takashi Uchiyama · 2005 · Retrovirology
  89. Emerging Drug Targets for Antiretroviral Therapy
    Jacqueline D. Reeves, Andrew John Piefer · 2005 · Drugs
  90. Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
    Iñigo Narvaiza, Daniel C. Linfesty, Benjamin N. Greener, Yoshiyuki Hakata, David J. Pintel, Eric C. Logue, Nathaniel Roy Landau, Matthew D. Weitzman · 2009 · PLoS Pathogens
  91. Characterization of the Alpha Interferon-Induced Postentry Block to HIV-1 Infection in Primary Human Macrophages and T Cells
    Caroline Goujon, Michael H. Malim · 2010 · Journal of Virology
  92. The Unexpected Roles of Eukaryotic Translation Elongation Factors in RNA Virus Replication and Pathogenesis
    Dongsheng Li, Ting Wei, Catherine M. Abbott, David Harrich · 2013 · Microbiology and Molecular Biology Reviews
  93. Virion-associated Uracil DNA Glycosylase-2 and Apurinic/Apyrimidinic Endonuclease Are Involved in the Degradation of APOBEC3G-edited Nascent HIV-1 DNA
    Bin Yang, Keyang Chen, Chune Zhang, Sophia Huang, Hui Zhang · 2007 · Journal of Biological Chemistry
  94. APOBEC‐mediated interference with hepadnavirus production†
    Christine Rösler, Josef Köck, Michael Kann, Michael H. Malim, Hubert Erich Blum, Thomas F. Baumert, Fritz von Weizsäcker · 2005 · Hepatology
  95. Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G
    Bindong Liu, Xianghui Yu, Kun Luo, Xiao-Fang Yu, Xiao-Fang Yu · 2004 · Journal of Virology
  96. Inhibition of a Yeast LTR Retrotransposon by Human APOBEC3 Cytidine Deaminases
    James A. Dutko, Alexandra Schäfer, Alison E. Kenny, Bryan R. Cullen, M. Joan Curcio · 2005 · Current Biology
  97. Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation
    Craig S. Pace, Jean Keller, David A Nolan, IAN R. JAMES, Silvana Gaudieri, Corey Moore, Simon Alexander Mallal · 2006 · Journal of Virology
  98. DNA-uracil and human pathology
    Mirta Mittelstedt Leal de Sousa, Hans Einar Krokan, Geir Slupphaug · 2007 · Molecular Aspects of Medicine
  99. Differential Sensitivity of Murine Leukemia Virus to APOBEC3-Mediated Inhibition Is Governed by Virion Exclusion
    Brian Doehle, Alexandra Schäfer, Heather L. Wiegand, Hal P. Bogerd, Bryan R. Cullen · 2005 · Journal of Virology
  100. Retroviral reverse transcriptases
    Alon Herschhorn, Amnon Hizi · 2010 · Cellular and Molecular Life Sciences